Tag archive for ‘Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; TASE: TEVA)’
Jewish Business News On Monday, June 2nd, 2014

Teva Announces New Organizational Structure and Senior Leadership Changes,

– Enabling the Global Integration of the Company and Positioning It for Short- and Long-Term Value Creation. – –  Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; TASE: TEVA) has announced More...

Globes On Thursday, May 15th, 2014

US court dismisses Teva suit to block generic Copaxone

– Mylan CEO Heather Bresch: Teva’s suit against the FDA was simply a desperate, last minute tactic.  – – “We continue to see no barrier to FDA approval of Mylan’s More...

Clive Minchom On Sunday, January 19th, 2014

Erez Vigodman’s Teva CEO Salary: $1.35 Million a Year

– Bonuses could boost Erez Vigodman’s compensation to $4.1 million annually, not including options. – – The basic salary of incoming Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; More...

Shiri Habib-Valdhorn On Monday, November 4th, 2013

JPMorgan Downgrades Teva Again

– JPMorgan has downgraded Teva to “Underweight”, just two months after downgrading it to “Neutral.” – JPMorgan has downgraded Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; More...

Globes On Sunday, October 27th, 2013

Jeremy Levin Teva CEO Threatens To Resign

– Jeremy Levin has threatened to resign because of interference by the board of directors. – Jeremy Levin – Israeli Channel 2 News reports that Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; More...

Globes On Wednesday, October 16th, 2013

Teva reportedly halts Copaxone supply in Russia

– Russia’s Federal Antimonopoly Service: Teva’s refusal to supply Copaxone is neither justified economically nor technologically. – Teva’s  Copaxone – /By Shiri Habib-Valdhorn More...

Wordpress site Developed by Fixing WordPress Problems